{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/unitedhealth-group-unh/",
 "dataUrl": "https://clearank.com/stock/unitedhealth-group-unh/data.json",
 "title": "UnitedHealth (UNH) Stock Forecast & Price Target (2026)",
 "description": "UnitedHealth Group Inc. (UNH) stock: Healthcare, Healthcare Plans. $338.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "UnitedHealth Group Inc. (UNH)",
 "published": "2026-06-21T09:09:53+00:00",
 "modified": "2026-09-26T17:26:25.991+00:00",
 "generated": "2026-09-27T15:08:57.225Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "UNH",
  "name": "UnitedHealth Group Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Healthcare Plans",
  "country": "United States",
  "website": "https://www.unitedhealthgroup.com"
 },
 "quote": {
  "price": 376.59,
  "previousClose": 375.01,
  "change": 1.58,
  "changePercent": 0.42,
  "open": 375.95001,
  "high": 379.17001,
  "low": 371.17001,
  "volume": 4077400,
  "averageVolume": 4951530,
  "marketCap": 338025243431,
  "fiftyTwoWeekHigh": 461.62,
  "fiftyTwoWeekLow": 255.97,
  "marketOpen": false,
  "asOf": "2026-09-26T17:26:25.000Z"
 },
 "statistics": {
  "pe": 24.1009,
  "eps": 15.56,
  "dividendYield": 0.024638911531113115,
  "beta": 0.622,
  "priceToSales": 0.7471424,
  "priceToBook": 3.4473853,
  "revenueTtm": 450525986816,
  "grossMargin": 0.20796736646672379,
  "returnOnEquity": 0.14152999
 },
 "technicals": {
  "rsi": 30.3,
  "macd": -7.17,
  "sma50": 399.38,
  "sma200": 355.43,
  "rsiSignal": "Bearish",
  "trend": "Bullish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 78,
  "consensus": "Buy",
  "fairValue": 490,
  "analystTarget": 490,
  "analystCount": 26,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-26T17:26:25.000Z",
  "priceAtAnalysis": 376.59,
  "volatility": {
   "daily": 1.18,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 369.06,
  "aggressiveEntry": 376.59,
  "stopLoss": 357.14,
  "stopLossPercent": 3.23,
  "targets": [
   387.51,
   405.96,
   424.42
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 275.89,
    "base": 409.81,
    "upside90th": 608.73
   },
   {
    "year": 2028,
    "downside10th": 254.84,
    "base": 445.95,
    "upside90th": 780.4
   },
   {
    "year": 2029,
    "downside10th": 244.54,
    "base": 485.29,
    "upside90th": 963.04
   },
   {
    "year": 2030,
    "downside10th": 239.34,
    "base": 528.09,
    "upside90th": 1165.2
   },
   {
    "year": 2031,
    "downside10th": 237.22,
    "base": 574.67,
    "upside90th": 1392.12
   },
   {
    "year": 2032,
    "downside10th": 237.24,
    "base": 625.35,
    "upside90th": 1648.4
   },
   {
    "year": 2033,
    "downside10th": 238.88,
    "base": 680.51,
    "upside90th": 1938.65
   },
   {
    "year": 2034,
    "downside10th": 241.82,
    "base": 740.53,
    "upside90th": 2267.79
   },
   {
    "year": 2035,
    "downside10th": 245.88,
    "base": 805.85,
    "upside90th": 2641.17
   },
   {
    "year": 2036,
    "downside10th": 250.92,
    "base": 876.93,
    "upside90th": 3064.73
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "UNH Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$375.95",
    "Day Range": "$371.17 to $379.17",
    "Prev Close": "$375.01",
    "Volume": "4.08M",
    "52-Week Range": "$255.97 to $461.62",
    "Market Cap": "$338.03B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a notable discount to sector peers (-24%), which may indicate undervaluation or specific company headwinds."
   ]
  },
  {
   "id": "financials",
   "title": "UNH Financial Performance",
   "text": [
    "Analysis: In the last 5 quarters, UNH beat estimates 3 times. The stock rose 3 times the next day. Price tends to react positively to beats."
   ]
  },
  {
   "id": "analysis",
   "title": "UNH Analysis",
   "text": [
    "UnitedHealth Group Inc. (UNH) is currently exhibiting bearish momentum, as indicated by its RSI value of 30.3. The stock is trading below its 50-day SMA ($399.38) and its 20-day EMA ($383.08), suggesting short-term downward pressure. The MACD is also negative at -7.17, reinforcing the bearish short-term outlook. Key support is found at the 200-day SMA of $355.43, while resistance lies at the 50-day SMA of $399.38. Volume has been below average recently, with the latest volume at 4.08 million compared to an average of 4.95 million, indicating a lack of strong conviction behind the current price action. The overall chart structure suggests a period of consolidation or potential further downside before a significant reversal.",
    "Insiders have purchased $31.6 million worth of UNH stock against only $1.1 million in sales, indicating significant confidence in the company's future performance.",
    "UNH recently beat EPS estimates by 29.67% for the quarter to June 2026, continuing a trend of positive earnings surprises that often drives stock price appreciation.",
    "The median Wall Street price target of $490.00 suggests a 30.1% upside potential from the current stock price, reflecting analyst optimism.",
    "The stock's RSI is at 30.3, indicating bearish momentum, and it is trading below its 50-day and 20-day moving averages, suggesting potential for further short-term declines.",
    "Projected revenue growth for the current year is 0.00%, indicating a lack of top-line expansion which could limit future earnings potential if not addressed.",
    "The base case outlook for UnitedHealth Group Inc. (UNH) suggests a potential recovery towards its median analyst target price of $490.00 within the next 6-12 months, driven by strong insider selling and solid fundamental performance. The company's ability to consistently beat earnings estimates provides a foundation for this optimism. Upside catalysts could include continued positive earnings surprises and favorable regulatory developments. Conversely, significant downside risks involve a failure to overcome current technical resistance levels, unexpected regulatory headwinds impacting the healthcare industry, or a slowdown in revenue growth. The company's projected revenue growth for next year is 3.00%, indicating a return to expansion."
   ],
   "lists": {
    "ProTips": [
     "Given the current technical weakness, consider waiting for a confirmed break above the 50-day SMA ($399.38) before initiating new long positions.",
     "The substantial insider buying activity, totaling over $31 million, is a strong signal of management's confidence in the company's future prospects.",
     "Monitor upcoming earnings reports and regulatory news closely, as these are key factors that could influence UNH's trajectory in the near to medium term."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Strong Insider Buying Activity",
     "text": "Insiders have purchased $31.6 million worth of UNH stock against only $1.1 million in sales, indicating significant confidence in the company's future performance.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bullish",
     "title": "Positive Earnings Surprises",
     "text": "UNH recently beat EPS estimates by 29.67% for the quarter to June 2026, continuing a trend of positive earnings surprises that often drives stock price appreciation.",
     "source": "Earnings Reports"
    },
    {
     "type": "Bullish",
     "title": "Analyst Price Target Upside",
     "text": "The median Wall Street price target of $490.00 suggests a 30.1% upside potential from the current stock price, reflecting analyst optimism.",
     "source": "Wall Street Analysts"
    },
    {
     "type": "Bearish",
     "title": "Bearish Technical Momentum",
     "text": "The stock's RSI is at 30.3, indicating bearish momentum, and it is trading below its 50-day and 20-day moving averages, suggesting potential for further short-term declines.",
     "source": "Technical Analysis"
    },
    {
     "type": "Neutral",
     "title": "Flat Projected Revenue Growth (Current Year)",
     "text": "Projected revenue growth for the current year is 0.00%, indicating a lack of top-line expansion which could limit future earnings potential if not addressed.",
     "source": "Revenue Estimates"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "UnitedHealth Group Inc. (UNH) presents a mixed valuation picture, trading at a P/E ratio of 24.10, which is below the Healthcare sector median of 31.9. Its price-to-sales ratio stands at 0.75, significantly lower than the sector median of 3.7, suggesting it may be undervalued on a sales basis. The company's return on equity is a healthy 14.15%, exceeding the sector median of 6.9%. However, its profit margin of 3.14% is slightly below the sector median of 8.1% (Note: sector median ROE is 6.9%, not profit margin). The debt-to-equity ratio of 0.69 is in line with the sector median. Despite the current technical weakness, the strong insider selling and positive earnings surprises provide a fundamental underpinning for potential recovery.",
    "UnitedHealth Group Inc. (UNH) demonstrated strong earnings performance in its most recent reported quarter, the quarter to June 2026. The company reported an actual EPS of $6.38, significantly beating the estimated $4.92 by 29.67%, leading to a positive price change of 0.64%. This follows a pattern of positive surprises, including a 9.55% beat in the quarter to March 2026. The company's revenue growth for the current quarter is estimated at -1.00% year-over-year, with current year revenue growth projected at 0.00%.",
    "A primary risk for UnitedHealth Group Inc. (UNH) is its current technical weakness, with the stock trading below key moving averages and exhibiting bearish RSI momentum. Additionally, while the company has a strong balance sheet, potential regulatory changes within the healthcare sector could impact future profitability and growth prospects. The projected revenue growth for the current year is flat, indicating a need for renewed top-line expansion to drive further stock appreciation."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "338.03B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "24.10"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "15.56"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "2.41%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "461.62"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "255.97"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Bearish SMA Cross Bullish Price vs SMA Bearish MACD Bearish Golden Cross in effect with the 50-day SMA ($399.38) above the 200-day SMA ($355.43), price is trading below the 50-day SMA."
   ],
   "facts": {
    "RSI": "Bearish",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "30.30"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-7.17"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "399.38"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "355.43"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.10",
    "Correlation with Nasdaq 100 (QQQ)": "+0.05",
    "Correlation with Bitcoin (BTC)": "+0.19",
    "Correlation with Gold (XAU)": "-0.01"
   }
  },
  {
   "id": "trade-plans",
   "title": "UNH Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (30.3) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$387.51",
    "TARGET 2": "$405.96",
    "TARGET 3": "$424.42",
    "STOP LOSS": "$357.14"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "-1.49%",
    "Average Feb return": "-3.55%",
    "Average Mar return": "+0.74%",
    "Average Apr return": "+5.27%",
    "Average May return": "-0.66%",
    "Average Jun return": "+1.79%",
    "Average Jul return": "+1.21%",
    "Average Aug return": "+1.98%",
    "Average Sep return": "-0.05%",
    "Average Oct return": "+4.34%",
    "Average Nov return": "+5.72%",
    "Average Dec return": "-1.52%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.18%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in UNH in September 2016 would be worth about $26,953 today, compared with about $36,004 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in UNH today could grow to about $23,286 by 2036 in the base case, with a bull case near $81,381 and a bear case around $6,663. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "UNH Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $528 for UNH by 2030 in the base case, from $377 today (1.4x over 4 years). The downside path ends near $239. These are outcomes of a Monte Carlo simulation run on UNH's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using UNH's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "UNH simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$276",
        "$410",
        "$609"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$255",
        "$446",
        "$780"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$245",
        "$485",
        "$963"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$239",
        "$528",
        "$1,165"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$237",
        "$575",
        "$1,392"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$237",
        "$625",
        "$1,648"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$239",
        "$681",
        "$1,939"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$242",
        "$741",
        "$2,268"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$246",
        "$806",
        "$2,641"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$251",
        "$877",
        "$3,065"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "OFIX Orthofix Medical Inc. NASDAQ $9.44 +3.06%",
     "url": "https://clearank.com/stock/ofix-stock-analysis/"
    },
    {
     "text": "BIIB Biogen Inc NASDAQ $227.60 +0.55%",
     "url": "https://clearank.com/stock/biib-stock-analysis/"
    },
    {
     "text": "VRTX Vertex Pharmaceuticals Incorporated NASDAQ $526.19 +0.73%",
     "url": "https://clearank.com/stock/vertex-vrtx/"
    },
    {
     "text": "ABBV AbbVie Inc. NYSE $264.34 -0.29%",
     "url": "https://clearank.com/stock/abbvie-abbv/"
    },
    {
     "text": "FBRX Forte Biosciences, Inc. NASDAQ $76.99 +0.00%",
     "url": "https://clearank.com/stock/fbrx-stock-analysis/"
    },
    {
     "text": "BMY Bristol-Myers Squibb Company NYSE $62.86 +2.21%",
     "url": "https://clearank.com/stock/bristol-myers-squibb-bmy/"
    },
    {
     "text": "NEOG Neogen Corp. NASDAQ $13.76 +0.73%",
     "url": "https://clearank.com/stock/neogen-neog/"
    },
    {
     "text": "DHR Danaher Corp. NYSE $224.49 +0.32%",
     "url": "https://clearank.com/stock/dhr-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Compare UNH",
   "links": [
    {
     "text": "UNH vs CI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/unh-vs-ci/"
    },
    {
     "text": "NXPI vs ON Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/nxpi-vs-on/"
    },
    {
     "text": "CRWD vs PANW Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/crwd-vs-panw/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "UNH Insider Trading Analysis",
   "facts": {
    "Bought": "$31.6M",
    "Sold": "$1.1M",
    "Insiders": "19",
    "Avg Transaction": "$3.3M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in UNH",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Jul 17, 2020",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "229.0K",
        "$70.4M"
       ]
      },
      {
       "label": "Oct 17, 2023",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "121.5K",
        "$65.7M"
       ]
      },
      {
       "label": "Oct 26, 2021",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "125.0K",
        "$56.4M"
       ]
      },
      {
       "label": "Jul 26, 2022",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "99.3K",
        "$53.1M"
       ]
      },
      {
       "label": "Dec 5, 2023",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "66.1K",
        "$36.4M"
       ]
      },
      {
       "label": "Oct 23, 2020",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "98.6K",
        "$32.5M"
       ]
      },
      {
       "label": "Aug 23, 2021",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "70.0K",
        "$29.8M"
       ]
      },
      {
       "label": "Jul 16, 2021",
       "cells": [
        "HEMSLEY STEPHEN J Director",
        "Sell",
        "60.0K",
        "$25.2M"
       ]
      },
      {
       "label": "Feb 16, 2024",
       "cells": [
        "THOMPSON BRIAN R Officer",
        "Sell",
        "28.9K",
        "$15.1M"
       ]
      },
      {
       "label": "Aug 18, 2022",
       "cells": [
        "MCMAHON DIRK C. President",
        "Sell",
        "14.7K",
        "$8.0M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=UnitedHealth+Group+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is UnitedHealth Group Inc. stock a buy right now?",
   "answer": "UnitedHealth Group Inc. (UNH) is currently rated a Buy with a consensus score of 78. The median analyst price target is $490.00, suggesting a 30.1% upside from the current price of $376.59. Strong insider selling further supports a bullish outlook."
  },
  {
   "question": "What is UNH's stock price prediction for 2030?",
   "answer": "Based on Monte Carlo simulations, UNH's stock price is projected to be $528.09 in 2030 under a base case scenario. The downside projection is $239.34, and the upside projection is $1165.20. These are statistical outcomes, not guarantees."
  },
  {
   "question": "What are the key risks facing UnitedHealth Group Inc.?",
   "answer": "Key risks include current technical weakness, with the stock below its 50-day SMA and showing bearish momentum. Potential regulatory changes in the healthcare sector and flat projected revenue growth for the current year also pose challenges."
  },
  {
   "question": "How does UNH's valuation compare to its sector peers?",
   "answer": "UNH trades at a P/E ratio of 24.10 and a price-to-sales ratio of 0.75, both of which are below the Healthcare sector medians of 31.9 and 3.7, respectively. Its return on equity of 14.15% significantly exceeds the sector median of 6.9%."
  },
  {
   "question": "What was UNH's most recent earnings performance?",
   "answer": "In the quarter to June 2026, UNH reported an EPS of $6.38, beating estimates by 29.67% and resulting in a positive stock price reaction. This continues a trend of positive earnings surprises."
  },
  {
   "question": "What is the Wall Street consensus for UNH stock?",
   "answer": "Wall Street analysts have a consensus rating of 'Buy' for UNH, with a median price target of $490.00. The overall Wall Street score is 78 out of 100, based on 26 analysts."
  },
  {
   "question": "Are insiders buying or selling UnitedHealth Group Inc. stock?",
   "answer": "insiders are net sellers of UNH stock, with total purchases of $31.6 million compared to $1.1 million in sales in recent filings. This moderate buying signal suggests insider confidence in the company's prospects."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "OFIX",
    "name": "Orthofix Medical Inc. NASDAQ",
    "price": "$9.44",
    "change": "+3.06%",
    "url": "https://clearank.com/stock/ofix-stock-analysis/"
   },
   {
    "ticker": "BIIB",
    "name": "Biogen Inc NASDAQ",
    "price": "$227.60",
    "change": "+0.55%",
    "url": "https://clearank.com/stock/biib-stock-analysis/"
   },
   {
    "ticker": "VRTX",
    "name": "Vertex Pharmaceuticals Incorporated NASDAQ",
    "price": "$526.19",
    "change": "+0.73%",
    "url": "https://clearank.com/stock/vertex-vrtx/"
   },
   {
    "ticker": "ABBV",
    "name": "AbbVie Inc. NYSE",
    "price": "$264.34",
    "change": "-0.29%",
    "url": "https://clearank.com/stock/abbvie-abbv/"
   },
   {
    "ticker": "FBRX",
    "name": "Forte Biosciences, Inc. NASDAQ",
    "price": "$76.99",
    "change": "+0.00%",
    "url": "https://clearank.com/stock/fbrx-stock-analysis/"
   },
   {
    "ticker": "BMY",
    "name": "Bristol-Myers Squibb Company NYSE",
    "price": "$62.86",
    "change": "+2.21%",
    "url": "https://clearank.com/stock/bristol-myers-squibb-bmy/"
   },
   {
    "ticker": "NEOG",
    "name": "Neogen Corp. NASDAQ",
    "price": "$13.76",
    "change": "+0.73%",
    "url": "https://clearank.com/stock/neogen-neog/"
   },
   {
    "ticker": "DHR",
    "name": "Danaher Corp. NYSE",
    "price": "$224.49",
    "change": "+0.32%",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "UNH vs CI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/unh-vs-ci/"
   },
   {
    "ticker": "NXPI vs ON Comparison",
    "name": "",
    "url": "https://clearank.com/compare/nxpi-vs-on/"
   },
   {
    "ticker": "CRWD vs PANW Comparison",
    "name": "",
    "url": "https://clearank.com/compare/crwd-vs-panw/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "NTES",
    "text": "NetEase, Inc.",
    "url": "https://clearank.com/stock/ntes-stock-analysis/"
   },
   {
    "ticker": "PCAR",
    "text": "PACCAR Inc.",
    "url": "https://clearank.com/stock/pcar-stock-analysis/"
   },
   {
    "ticker": "O",
    "text": "Realty Income Corp.",
    "url": "https://clearank.com/stock/o-stock-analysis/"
   },
   {
    "ticker": "SPG",
    "text": "Simon Property Group Inc.",
    "url": "https://clearank.com/stock/spg-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "SUI/USD",
    "text": "↑ 11.97%",
    "url": "https://clearank.com/crypto/sui-sui-usd/"
   },
   {
    "ticker": "KAS/USD",
    "text": "↑ 11.85%",
    "url": "https://clearank.com/crypto/kaspa-kas-usd/"
   },
   {
    "ticker": "RENDER/USD",
    "text": "↑ 10.19%",
    "url": "https://clearank.com/crypto/render-render-usd/"
   },
   {
    "ticker": "ZS",
    "text": "↓ 10.06%",
    "url": "https://clearank.com/stock/zscaler-zs/"
   },
   {
    "ticker": "MXL",
    "text": "↑ 10.00%",
    "url": "https://clearank.com/stock/mxl-stock-analysis/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "CVS",
    "text": "CVS Health",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "ELV",
    "text": "Elevance Health",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "HUM",
    "text": "Humana Inc",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "MOH",
    "text": "Molina Healthcare Inc.",
    "url": "https://clearank.com/stock/moh-stock-analysis/"
   },
   {
    "ticker": "OSCR",
    "text": "Oscar Health",
    "url": "https://clearank.com/stock/oscr-stock-analysis/"
   }
  ],
  "news": [
   {
    "title": "UnitedHealth at 5-Year Lows: Why This May Be a Rare Buying Moment",
    "date": "May 20, 2025",
    "url": "/news/unitedhealth-stock-buy-opportunity/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/unh-analysis-2026-06.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/unh-analysis-2026-06.png",
     "width": "1280",
     "height": "720",
     "caption": "UnitedHealth Group (UNH) stock price analysis chart for June 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/unitedhealth-group-unh/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/unitedhealth-group-unh/",
        "name": "UnitedHealth Group (UNH) Stock Price Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/unitedhealth-group-unh/#webpage",
     "url": "https://clearank.com/stock/unitedhealth-group-unh/",
     "name": "UnitedHealth (UNH) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-06-21T09:09:53+00:00",
     "dateModified": "2026-09-26T17:26:25+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/unh-analysis-2026-06.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/unitedhealth-group-unh/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/unitedhealth-group-unh/#richSnippet",
     "headline": "UnitedHealth (UNH) Stock Forecast & Price Target (2026)",
     "name": "UnitedHealth (UNH) Stock Forecast & Price Target (2026)",
     "description": "UnitedHealth Group Inc. (UNH) stock: Healthcare, Healthcare Plans. $338.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-06-21T09:09:53+00:00",
     "dateModified": "2026-09-26T17:26:25+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "UnitedHealth Group Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "UNH"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "UnitedHealth Group Inc. is a diversified health care company that provides health benefits, care delivery, pharmacy services, and data-driven health services. The company operates through UnitedHealthcare and Optum, serving individuals, employers, government programs, and health care organizations w",
      "tickerSymbol": "UNH",
      "sameAs": "https://www.unitedhealthgroup.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/unitedhealth-group-unh/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/unh-analysis-2026-06.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/unitedhealth-group-unh/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is UnitedHealth Group Inc. stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "UnitedHealth Group Inc. (UNH) is currently rated a Buy with a consensus score of 78. The median analyst price target is $490.00, suggesting a 30.1% upside from the current price of $376.59. Strong insider buying further supports a bullish outlook."
     }
    },
    {
     "@type": "Question",
     "name": "What is UNH's stock price prediction for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, UNH's stock price is projected to be $528.09 in 2030 under a base case scenario. The downside projection is $239.34, and the upside projection is $1165.20. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks facing UnitedHealth Group Inc.?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks include current technical weakness, with the stock below its 50-day SMA and showing bearish momentum. Potential regulatory changes in the healthcare sector and flat projected revenue growth for the current year also pose challenges."
     }
    },
    {
     "@type": "Question",
     "name": "How does UNH's valuation compare to its sector peers?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "UNH trades at a P/E ratio of 24.10 and a price-to-sales ratio of 0.75, both of which are below the Healthcare sector medians of 31.9 and 3.7, respectively. Its return on equity of 14.15% significantly exceeds the sector median of 6.9%."
     }
    },
    {
     "@type": "Question",
     "name": "What was UNH's most recent earnings performance?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "In the quarter to June 2026, UNH reported an EPS of $6.38, beating estimates by 29.67% and resulting in a positive stock price reaction. This continues a trend of positive earnings surprises."
     }
    },
    {
     "@type": "Question",
     "name": "What is the Wall Street consensus for UNH stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Wall Street analysts have a consensus rating of 'Buy' for UNH, with a median price target of $490.00. The overall Wall Street score is 78 out of 100, based on 26 analysts."
     }
    },
    {
     "@type": "Question",
     "name": "Are insiders buying or selling UnitedHealth Group Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders are net buyers of UNH stock, with total purchases of $31.6 million compared to $1.1 million in sales across 143 transactions. This moderate buying signal suggests insider confidence in the company's prospects."
     }
    }
   ]
  }
 ]
}